Our Blog
Blog Post
12 Resume Tips That Can Help You Get a Clinical Research Job
Here are some resume and CV tips to help you stand out with the recruiters, hiring managers, and interview teams that make the difference between getting an interview or a rejection letter for the clinical research job you really want.
Blog Post
Could Your Drug Development Program Benefit from an NDA/BLA/PMA Gap Analysis?
Whether you plan to file a new drug application (NDA), a biologics license application (BLA), or a premarket approval application (PMA) with the FDA or a marketing authorization application (MAA) with the European Medicines Agency, you’ll need an in depth understanding of how the data you have from your clinical studies, nonclinical studies, and Chemistry, Manufacturing and Controls (CMC) / Quality development map to the requirements of the application.
Blog Post
How much does a clinical trial cost? Understanding the 8 major factors driving CRO bids
“How much does a clinical trial cost?” This is a question we frequently get in some form from Sponsors in early phases of development that are trying to figure out what it will cost to hire a CRO to conduct their clinical trials and associated regulatory activities. While the high degree in variability between trials would make it difficult to provide a single answer, we can explain what factors can drive costs up or down.
Blog Post
Heat Maps for Database Lock
Preparing a database for lock can be a burdensome process and requires coordinated effort from an entire clinical study team. The team must work together to ensure the accuracy and reliability of the data, but with so many sites, subjects, visits, case report forms (CRFs), and data points it can be difficult to stay on top of the entire process.
Blog Post
10-Step Commercial Clinical Protocol Authoring Guide
Before the protocol authoring process even begins, a variety of activities and decisions are necessary to establish a strategy for success. The following steps provide concepts and considerations that are essential in formulating the details that will become the protocol synopsis and ultimately the clinical study protocol.
Blog Post
Key Takeaways from the 2nd Annual Strategies in Patient Centered Clinical Research Conference
Patient centricity is garnering broad attention in our industry, but finding time to thoroughly explore the principles and practices of the movement can be difficult. We were excited to spend two full days immersed in discussion and collaboration with some of the industry pioneers in patient-centered clinical research. We wanted to share our take on the main themes and trends that stood out to us from the event.
Blog Post
Mining Metadata for Clinical Research Activities
As anyone involved in clinical database creation knows, considerable resources are devoted to the development and validation of electronic data capture (EDC) systems. Once these databases are live and clinical data begin coming in, various processes for setting up data cleaning programming, database quality review, and reporting are put into play.
Blog Post
Beating the Odds: 5 Strategies to Improve Clinical Trial Enrollment
Hitting the clinical trial enrollment goal is not only important to meeting overall study timelines and budgets, it is critical to the success of the clinical study. If you don’t have enough participants, you won’t have enough data to support your objectives. That’s why it’s important to plan for enrollment just as you would plan for collecting and analyzing the data.
Blog Post
10 Interviewing Tips for Jobs in Clinical Research
Are you interested in a job in clinical research? Get a head start from our experienced Rho expert with these tips that can help you stand out in the interview process.
Blog Post
Why Depression Studies So Often Fail: Don’t Blame “Placebo Response”
After careful review of internal and external data, as well as published explanations for high “placebo response rates” in clinical depression trials (much of which also applies to clinical trials in general), three factors emerged as being of particular importance because they are easily mitigated by proper trial design, thorough research staff training, and meticulous oversight of study conduct.